Wellness Index Report, an independent wellness ratings and education platform, has published a new Inside the Index feature recognizing Nefense as a leader in nasal health innovation. The report examines the growing consumer shift toward drug-free alternatives for respiratory hygiene and infection control, spotlighting Nefense's hypochlorous acid (HOCl) and xylitol-based nasal solutions.
The feature reviews emerging research on hypochlorous acid, noting its antimicrobial and anti-inflammatory properties, which have drawn interest for potential applications in respiratory health and infection control. According to the report, Nefense offers doctor-recommended, ENT-approved products formulated under the direction of Dr. Richard Downs, DDS, providing a drug-free alternative to traditional over-the-counter nasal sprays.
Wellness Index Report's analysis aligns with broader consumer trends prioritizing non-pharmaceutical approaches to wellness. The platform, founded by Lindsay O'Neill-O'Keefe, aims to help consumers and medical providers identify evidence-informed wellness solutions through expert review, customer feedback, and scientific evaluation. Its Inside the Index editorial series highlights companies and technologies shaping the future of wellness and longevity.
For more details on the recognition, view the full announcement here.
